Clinical Trials

46 enrolled

Esophageal Squamous Cell Carcinoma

NCT06408116 2026-03-10

PEGASUS

30 enrolled

Esophageal Neoplasms

NCT04975516 2026-03-03

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Phase 2 Terminated

3 enrolled

Pancreatic Neoplasms

NCT07437898 2026-02-27

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

42 enrolled

Esophageal Squamous Cell Carcinoma

NCT07425054 2026-02-20

HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

33 enrolled

Anus Neoplasms

NCT02738606 2026-02-17

Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Phase 2 Terminated

29 enrolled 8 charts

Colorectal Neoplasms

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT04643366 2026-01-27

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

54 enrolled

Rectal Neoplasms

NCT05978193 2026-01-22

SCR-ESCC-01

100 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07042685 2026-01-16

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer

50 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

38 enrolled

Pancreatic Cancer Liver Metastases

NCT03599752 2026-01-09

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

40 enrolled

Colorectal Neoplasms

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

96 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07279077 2025-12-26

MODIFI-L

38 enrolled

Colonic Neoplasms

NCT07290010 2025-12-17

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

25 enrolled

Esophageal Squamous Cell Carcinoma

NCT06925516 2025-11-28

ACADEMY

38 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT03161522 2025-10-23

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

100 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT06848842 2025-10-01

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

40 enrolled

Colorectal Liver Metastases

NCT07161115 2025-09-15

REFIRT

Rectal Neoplasms

NCT07097064 2025-07-31

RAIPANC

160 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT06048913 2025-07-04

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

56 enrolled

Esophageal Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

50 enrolled

Esophageal Neoplasms, Esophagitis

NCT06165380 2025-06-26

Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT06370663 2025-06-25

First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

Phase 2 Terminated

1 enrolled

Cholangiocarcinoma

NCT06728657 2025-06-18

TORCH-G

Phase 2 Suspended

68 enrolled

Stomach Adenocarcinoma

NCT04625803 2025-06-17

Neoadjuvant Therapy for Locally Advanced Colon Cancer

64 enrolled 11 charts

Colonic Neoplasms

NCT06949098 2025-05-29

Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer

Rectal Neoplasms

NCT06962267 2025-05-08

A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)

50 enrolled

Pancreatic Neoplasms

NCT06521866 2025-03-14

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer

208 enrolled

Advanced Colorectal Carcinoma

NCT06814158 2025-02-07

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

57 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT06767007 2025-01-22

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

31 enrolled

Unresectable Locally Recurrent Rectal Cancer

NCT06709417 2024-11-29

A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)

52 enrolled

Esophageal Squamous Cell Carcinoma

NCT03985046 2024-11-07

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

75 enrolled

Esophageal Squamous Cell Carcinoma

NCT06667050 2024-10-31

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

58 enrolled

Gastric Adenocarcinoma

NCT06665087 2024-10-30

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

110 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

25 enrolled

Pancreatic Neoplasms

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

14 enrolled 14 charts

Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

180 enrolled

Anus Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT02826486 2024-08-28

COMBAT

80 enrolled 13 charts

Metastatic Pancreatic Adenocarcinoma

NCT06513221 2024-07-22

A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab

100 enrolled

Colorectal Neoplasms

NCT06359275 2024-06-25

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

81 enrolled

Pancreatic Neoplasms

NCT06084897 2024-06-14

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

120 enrolled

Esophageal Neoplasms

NCT06422156 2024-05-20

Nim-PC-28

73 enrolled

Advanced Pancreatic Cancer

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05975749 2024-03-12

Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer

114 enrolled

Stomach Neoplasms

NCT06304545 2024-03-12

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

48 enrolled

Rectal Neoplasms

NCT06254521 2024-02-12

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Rectal Neoplasms

NCT04568200 2024-01-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma